Analysis of the Application of Leucocyte Increasing Drugs in Lung Cancer Patients of 11 Zhejiang Hospi-tals during 2009-2014
10.6039/j.issn.1001-0408.2016.08.04
- VernacularTitle:浙江地区11家医院2009－2014年肺癌患者升白细胞药物应用分析
- Author:
Wenxiu XIN
;
Lingya CHEN
;
Zeng WANG
;
Xiaowei ZHENG
;
Zhongjian CHEN
;
Yinghui TONG
- Publication Type:Journal Article
- Keywords:
Leucocyte increasing drugs;
Lung cancer;
Consumption sum;
DDDs;
DDC;
Analysis of drug use
- From:
China Pharmacy
2016;27(8):1020-1023
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To provide reference for rational use of leucocyte increasing drugs in patients with lung cancer. METHODS:The application of drugs in lung cancer patients in 40 d each year were collected from 11 Zhejiang hospitals during 2009-2014,and then analyzed retrospectively in consumption sum,DDDs,DDC and department distribution,etc. RESULTS:The proportion of consumption sum of leucocyte increasing drugs in total consumption sum decreased generally in 11 Zhejiang hospital during 2009-2014,decreasing from 781 995.50 yuan in 2009(3.28%)to 626 792.80 yuan in 2014(1.53%). Top 3 departments in the list of consumption sum of leucocyte increasing drugs were oncology department(29.00%),radiotherapy department(27.08%) and respiratory medicine department(9.93%). Top 3 drugs in the list of consumption sum during 2009-2014 were recombinant hu-man granulocyte colony-stimulating factor,Coenzyme complex for injection and Leucogen tablets;top 3 drugs in the list of DDDs were Leucogen tablets,Berbamine tablet and recombinant human granulocyte colony-stimulating factor;Coenzyme complex for in-jection,recombinant human granulocyte colony-stimulating factor and human GM-CSF took the first three place in the list of DDC during 2009-2013,and Leucogen tablets were the top one in 2014. CONCLUSIONS:The application of leucocyte increasing drugs in lung cancer patients is decreasing year by year in 11 Zhejiang hospitals,and those with definite therapeutic efficacy and moder-ate price predominate clinical application predominate in the clinical practive.
